Your browser doesn't support javascript.
loading
Stricturing Crohn's Disease Single-Cell RNA Sequencing Reveals Fibroblast Heterogeneity and Intercellular Interactions.
Mukherjee, Pranab K; Nguyen, Quang Tam; Li, Jiannan; Zhao, Shuai; Christensen, Stephen M; West, Gail A; Chandra, Jyotsna; Gordon, Ilyssa O; Lin, Sinan; Wang, Jie; Mao, Ren; Czarnecki, Douglas; Rayan, Carla; Goren, Idan; Banerjee, Suhanti; Kotak, Prerna; Plesec, Thomas; Lal, Samir; Fabre, Thomas; Asano, Shoh; Bound, Kathryn; Hart, Kevin; Park, Chanyoung; Martinez, Robert; Dower, Ken; Wynn, Thomas A; Hu, Shaomin; Naydenov, Nayden; Decaris, Martin; Turner, Scott; Holubar, Stefan D; Steele, Scott R; Fiocchi, Claudio; Ivanov, Andrei I; Kravarik, Kellie M; Rieder, Florian.
Afiliación
  • Mukherjee PK; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio; Center for Global Translational Inflammatory Bowel Disease Research, Cleveland Clinic, Cleveland, Ohio.
  • Nguyen QT; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio; Center for Global Translational Inflammatory Bowel Disease Research, Cleveland Clinic, Cleveland, Ohio.
  • Li J; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.
  • Zhao S; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.
  • Christensen SM; Worldwide Research, Development and Medicine, Pfizer Inc, Cambridge, Massachusetts.
  • West GA; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.
  • Chandra J; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio; Center for Global Translational Inflammatory Bowel Disease Research, Cleveland Clinic, Cleveland, Ohio.
  • Gordon IO; Department of Pathology, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic Foundation, Cleveland, Ohio; Center for Global Translational Inflammatory Bowel Disease Research, Cleveland Clinic, Cleveland, Ohio.
  • Lin S; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio; Department of Gastroenterology and Hepatology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Wang J; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio; Henan Key Laboratory of Immunology and Targeted Drug, Xinxiang Medical University, Xinxiang, Henan Province, China.
  • Mao R; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio; Department of Gastroenterology and Hepatology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Czarnecki D; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.
  • Rayan C; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.
  • Goren I; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.
  • Banerjee S; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.
  • Kotak P; Pliant Therapeutics, South San Francisco, California.
  • Plesec T; Department of Pathology, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic Foundation, Cleveland, Ohio; Center for Global Translational Inflammatory Bowel Disease Research, Cleveland Clinic, Cleveland, Ohio.
  • Lal S; Worldwide Research, Development and Medicine, Pfizer Inc, Cambridge, Massachusetts.
  • Fabre T; Worldwide Research, Development and Medicine, Pfizer Inc, Cambridge, Massachusetts.
  • Asano S; Worldwide Research, Development and Medicine, Pfizer Inc, Cambridge, Massachusetts.
  • Bound K; Worldwide Research, Development and Medicine, Pfizer Inc, Cambridge, Massachusetts.
  • Hart K; Worldwide Research, Development and Medicine, Pfizer Inc, Cambridge, Massachusetts.
  • Park C; Worldwide Research, Development and Medicine, Pfizer Inc, Cambridge, Massachusetts; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts.
  • Martinez R; Worldwide Research, Development and Medicine, Pfizer Inc, Cambridge, Massachusetts.
  • Dower K; Worldwide Research, Development and Medicine, Pfizer Inc, Cambridge, Massachusetts.
  • Wynn TA; Worldwide Research, Development and Medicine, Pfizer Inc, Cambridge, Massachusetts.
  • Hu S; Department of Pathology, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic Foundation, Cleveland, Ohio; Center for Global Translational Inflammatory Bowel Disease Research, Cleveland Clinic, Cleveland, Ohio.
  • Naydenov N; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.
  • Decaris M; Pliant Therapeutics, South San Francisco, California.
  • Turner S; Pliant Therapeutics, South San Francisco, California.
  • Holubar SD; Department of Colorectal Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, Ohio; Center for Global Translational Inflammatory Bowel Disease Research, Cleveland Clinic, Cleveland, Ohio.
  • Steele SR; Department of Colorectal Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, Ohio.
  • Fiocchi C; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio; Department of Gastroenterology, Hepatology and Nutrition, Digestive Disease Institute, Cleveland Clinic, Cleveland, Ohio.
  • Ivanov AI; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio; Center for Global Translational Inflammatory Bowel Disease Research, Cleveland Clinic, Cleveland, Ohio.
  • Kravarik KM; Worldwide Research, Development and Medicine, Pfizer Inc, Cambridge, Massachusetts.
  • Rieder F; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio; Department of Gastroenterology, Hepatology and Nutrition, Digestive Disease Institute, Cleveland Clinic, Cleveland, Ohio; Center for Global Translational Inflammatory Bowel Disease Research, Clevel
Gastroenterology ; 165(5): 1180-1196, 2023 Nov.
Article en En | MEDLINE | ID: mdl-37507073
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Crohn / Colitis Límite: Animals Idioma: En Revista: Gastroenterology Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Crohn / Colitis Límite: Animals Idioma: En Revista: Gastroenterology Año: 2023 Tipo del documento: Article